The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

PART 5 U.K. Amendment of Part 5 (marketing authorisations)

[F1 Amendment of regulation 79 (failure to provide information on marketing authorisations to EMA) U.K.

88.   In regulation 79 (failure to provide information on marketing authorisations to EMA)—

(a) in paragraph (1), for the first reference to “a marketing authorisation” substitute “a UKMA(NI) or UKMA(UK)”;

(b) in paragraph (2), for the first reference to “a marketing authorisation” substitute “UKMA(NI) or UKMA(UK)”.]

Textual Amendments

F1 Reg. 88 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 65

Commencement Information

I1 Reg. 88 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1